全文获取类型
收费全文 | 7961篇 |
免费 | 537篇 |
国内免费 | 51篇 |
专业分类
耳鼻咽喉 | 54篇 |
儿科学 | 219篇 |
妇产科学 | 231篇 |
基础医学 | 1198篇 |
口腔科学 | 174篇 |
临床医学 | 721篇 |
内科学 | 1966篇 |
皮肤病学 | 226篇 |
神经病学 | 932篇 |
特种医学 | 156篇 |
外科学 | 722篇 |
综合类 | 17篇 |
一般理论 | 2篇 |
预防医学 | 588篇 |
眼科学 | 97篇 |
药学 | 500篇 |
中国医学 | 18篇 |
肿瘤学 | 728篇 |
出版年
2024年 | 4篇 |
2023年 | 111篇 |
2022年 | 182篇 |
2021年 | 376篇 |
2020年 | 254篇 |
2019年 | 297篇 |
2018年 | 323篇 |
2017年 | 236篇 |
2016年 | 284篇 |
2015年 | 323篇 |
2014年 | 410篇 |
2013年 | 532篇 |
2012年 | 779篇 |
2011年 | 788篇 |
2010年 | 417篇 |
2009年 | 367篇 |
2008年 | 549篇 |
2007年 | 496篇 |
2006年 | 437篇 |
2005年 | 377篇 |
2004年 | 314篇 |
2003年 | 252篇 |
2002年 | 202篇 |
2001年 | 31篇 |
2000年 | 14篇 |
1999年 | 24篇 |
1998年 | 29篇 |
1997年 | 29篇 |
1996年 | 24篇 |
1995年 | 19篇 |
1994年 | 5篇 |
1993年 | 6篇 |
1992年 | 9篇 |
1991年 | 5篇 |
1990年 | 7篇 |
1989年 | 2篇 |
1988年 | 3篇 |
1987年 | 3篇 |
1986年 | 5篇 |
1985年 | 3篇 |
1984年 | 2篇 |
1983年 | 3篇 |
1981年 | 3篇 |
1977年 | 3篇 |
1976年 | 1篇 |
1974年 | 1篇 |
1972年 | 1篇 |
1967年 | 2篇 |
1966年 | 1篇 |
1931年 | 1篇 |
排序方式: 共有8549条查询结果,搜索用时 609 毫秒
941.
The effect of two lysosomotropic agents, NH4Cl and chloroquine, on the foot-and-mouth disease virus (FMDV) replicative cycle was studied. When the drugs were present throughout the viral replicative cycle, an important inhibition of viral RNA synthesis and virus production was detected. The inhibition of viral RNA synthesis was maximal when the drugs were present from 30 min before virus infection up to 30 min after that. Otherwise, if the agents were added once the viral synthesis has started (150 min p.i.) the effect was not evident. The agents neither exerted direct virucidal effects, nor did they affect viral adsorption. The results indicate that the lysosomotropic agents affect preferentially an early intracellular event during the viral infective cycle. 相似文献
942.
In perceptual learning, performance usually improves when observers train with one type of stimulus, for example, a bisection stimulus. Roving denotes the situation when, instead of one, two or more types of stimuli are presented randomly interleaved, for example, a bisection stimulus and a vernier. For some combinations of stimulus types, performance improves in roving situations whereas for others it does not. To investigate when roving impedes perceptual learning, we conducted four experiments. Performance improved, for example, when we roved a bisection stimulus and a vernier but not when we roved certain types of bisection stimuli. We propose that roving hinders perceptual learning when the stimulus types are clearly distinct from each other but still excite overlapping but not identical neural populations. 相似文献
943.
944.
945.
Arcaini L Colombo N Bernasconi P Calatroni S Passamonti F Orlandi E Bonfichi M Burcheri S Porta MD Rumi E Montanari F Algarotti A Pascutto C Lazzarino M 《Leukemia & lymphoma》2006,47(6):1018-1022
Bcl-2/IgH rearrangement is the molecular hallmark of follicular lymphoma which is present in 70 - 90% of cases at diagnosis. The significance of the bcl-2 rearrangement at onset of disease and of its clearing after treatment (molecular response) is still controversial.
The aims of the present analysis are: to evaluate the incidence of bcl-2 rearrangement in blood and marrow in a cohort of patients systematically investigated at diagnosis, to describe the correlation between bcl-2 and presenting features, to clarify the correlation of molecular response with outcome.
Of 98 patients studied at initial staging for the presence of bcl-2 rearrangement, 64 (65%) showed bcl-2/IgH rearrangement in peripheral blood (PB) and/or bone marrow (BM) (58 at Major Breakpoint Region, MBR, and 6 at minor cluster region, mcr) while no bcl-2/IgH rearrangement was detected in the remaining 34 (35%) (germline status). No statistically significant differences were found between bcl-2 positive and bcl-2 negative cases as concerns presenting clinical features and response to first-line therapy. The median event-free survival, EFS, was not reached for the bcl-2 negative patients in PB and was 11 months for bcl-2 positive patients (statistically significant, P = 0.01) and, similarly, the median EFS was not reached for the bcl-2 negative patients in BM and was 11 months for bcl-2 positive patients (statistically significant, P = 0.04).
Of the 64 bcl-2 positive cases, patients were analysed for molecular response (48 in BM and 40 in PB): 16 were molecular responders in BM and 20 were molecular responders in PB. The median EFS was 19 months for molecular responders in PB and 9 months for non-responders; 1-year-EFS was 68% (95% CI; 49 - 88), for responders in PB and 42% (95% CI; 22 - 61) for non-responders (P = 0.05). The median EFS was 11 months both for molecular responders and non-responders in BM; 1-year-EFS was 52% for responders in BM (CI; 30 - 73), and 43% (CI 33 - 71) for non-responders (P = 0.7). No clinical feature showed significant correlation with PB and BM molecular responses.
This analysis shows that bcl-2 rearrangement in blood and bone marrow is frequently detected at staging, even in stage I disease. Absence of the bcl-2 rearrangement is related to a better EFS and the achievement of a molecular response in peripheral blood after therapy is associated with a better EFS. 相似文献
The aims of the present analysis are: to evaluate the incidence of bcl-2 rearrangement in blood and marrow in a cohort of patients systematically investigated at diagnosis, to describe the correlation between bcl-2 and presenting features, to clarify the correlation of molecular response with outcome.
Of 98 patients studied at initial staging for the presence of bcl-2 rearrangement, 64 (65%) showed bcl-2/IgH rearrangement in peripheral blood (PB) and/or bone marrow (BM) (58 at Major Breakpoint Region, MBR, and 6 at minor cluster region, mcr) while no bcl-2/IgH rearrangement was detected in the remaining 34 (35%) (germline status). No statistically significant differences were found between bcl-2 positive and bcl-2 negative cases as concerns presenting clinical features and response to first-line therapy. The median event-free survival, EFS, was not reached for the bcl-2 negative patients in PB and was 11 months for bcl-2 positive patients (statistically significant, P = 0.01) and, similarly, the median EFS was not reached for the bcl-2 negative patients in BM and was 11 months for bcl-2 positive patients (statistically significant, P = 0.04).
Of the 64 bcl-2 positive cases, patients were analysed for molecular response (48 in BM and 40 in PB): 16 were molecular responders in BM and 20 were molecular responders in PB. The median EFS was 19 months for molecular responders in PB and 9 months for non-responders; 1-year-EFS was 68% (95% CI; 49 - 88), for responders in PB and 42% (95% CI; 22 - 61) for non-responders (P = 0.05). The median EFS was 11 months both for molecular responders and non-responders in BM; 1-year-EFS was 52% for responders in BM (CI; 30 - 73), and 43% (CI 33 - 71) for non-responders (P = 0.7). No clinical feature showed significant correlation with PB and BM molecular responses.
This analysis shows that bcl-2 rearrangement in blood and bone marrow is frequently detected at staging, even in stage I disease. Absence of the bcl-2 rearrangement is related to a better EFS and the achievement of a molecular response in peripheral blood after therapy is associated with a better EFS. 相似文献
946.
Bv8, the amphibian homologue of the mammalian prokineticins, induces a proinflammatory phenotype of mouse macrophages 总被引:3,自引:0,他引:3
Martucci C Franchi S Giannini E Tian H Melchiorri P Negri L Sacerdote P 《British journal of pharmacology》2006,147(2):225-234
1.--The small protein Bv8, isolated from the amphibian skin, belongs to a novel family of secreted proteins linked to several biological effects. We describe the expression of Bv8/prokineticins and their receptors in mouse macrophages, and characterize their proinflammatory activities. 2.--The rodent analogue of Bv8, prokineticin-2, is expressed by macrophages, as well as its G-protein-coupled receptor prokineticin receptor (PKR-1 and PKR-2). PKR-1 is expressed more abundantly. 3.-- Bv8 induces potent chemotaxis of macrophages at concentrations as low as 10(-12) M. 4.-- It stimulates lipopolysaccharide-induced production of the proinflammatory cytokines IL-1 and IL-12, reducing that of the anti-inflammatory cytokine IL-10. The effects are observed starting at the very low concentration of 10(-11) M. 5.--Effects on chemotaxis and cytokine are not pertussis-toxin sensitive, but are completely prevented by addition of the phospholipase inhibitor U73122, suggesting a G(q) protein is involved in the Bv8-induced effects. 6.--Studies in PKR-1 knockout mice indicate that all the activities exerted by Bv8 on macrophages are mediated by the PKR-1 receptor. 7.--In conclusion, Bv8 appears to be able to induce the macrophage to migrate and to acquire a proinflammatory phenotype. 相似文献
947.
Identification of ellagic acid as potent inhibitor of protein kinase CK2: a successful example of a virtual screening application 总被引:5,自引:0,他引:5
Cozza G Bonvini P Zorzi E Poletto G Pagano MA Sarno S Donella-Deana A Zagotto G Rosolen A Pinna LA Meggio F Moro S 《Journal of medicinal chemistry》2006,49(8):2363-2366
Casein kinase 2 (CK2) is a ubiquitous, essential, and highly pleiotropic protein kinase whose abnormally high constitutive activity is suspected to underlie its pathogenic potential in neoplasia and other diseases. Using a virtual screening approach, we have identified the ellagic acid, a naturally occurring tannic acid derivative, as a novel potent CK2 inhibitor. At present, ellagic acid represents the most potent known CK2 inhibitor (K(i) = 20 nM). 相似文献
948.
Carter MC Alber DG Baxter RC Bithell SK Budworth J Chubb A Cockerill GS Dowdell VC Henderson EA Keegan SJ Kelsey RD Lockyer MJ Stables JN Wilson LJ Powell KL 《Journal of medicinal chemistry》2006,49(7):2311-2319
Respiratory syncytial virus (RSV) is the cause of one-fifth of all lower respiratory tract infections worldwide and is increasingly being recognized as a serious threat to patient groups with poorly functioning immune systems. Our approach to finding a novel inhibitor of this virus was to screen a 20 000-member diverse library in a whole cell XTT assay. Parallel assays were carried out in the absence of virus in order to quantify any associated cell toxicity. This identified 100 compounds with IC(50)'s less than 50 muM. A-33903 (18), a 1,4-benzodiazepine analogue, was chosen as the starting point for lead optimization. This molecule was moderately active and demonstrated good pharmacokinetic properties. The most potent compounds identified from this work were A-58568 (47), A-58569 (44), and A-62066 (46), where modifications to the aromatic substitution enhanced potency, and A-58175 (42), where the amide linker was modified. 相似文献
949.
Two new 99mTc-labeled neurotensin(8-13) analogues containing the retro-N(alpha)-carboxymethyl-histidine ((N(alpha)His)Ac) chelator were synthesized as potential radiopharmaceuticals for visualization of pancreatic carcinoma. To improve the pharmacokinetic properties, (N(alpha)His)Ac-Arg-NMeArg-Pro-Tyr-Tle-Leu (NT-XII), which is metabolically stabilized at two positions, was further modified. Shikimic acid (3,4,5-trihydroxy-1-cyclohexene-1-carboxylic acid) was introduced to obtain a more hydrophilic peptide (NT-XVIII), or Tyr11 was replaced by 2,6-dimethyltyrosine (Dmt) resulting in a triple-stabilized NT(8-13) analogue (NT-XIX). The latter has the best biodistribution profile. 相似文献
950.
Vázquez ME Blanco JB Salvadori S Trapella C Argazzi R Bryant SD Jinsmaa Y Lazarus LH Negri L Giannini E Lattanzi R Colucci M Balboni G 《Journal of medicinal chemistry》2006,49(12):3653-3658
A new environment-sensitive fluorophore, 6-N,N-(dimethylamino)-2,3-naphthalimide (6DMN) was introduced in the delta-selective opioid peptide agonist H-Dmt-Tic-Glu-NH(2) and in the mu-selective opioid peptide agonist endomorphin-2 (H-Tyr-Pro-Phe-Phe-NH(2)). Environment-sensitive fluorophores are a special class of chromophores that generally exhibit a low quantum yield in aqueous solution but become highly fluorescent in nonpolar solvents or when bound to hydrophobic sites in proteins or membranes. New fluorescent delta-selective irreversible antagonists (H-Dmt-Tic-Glu-NH-(CH(2))(5)-CO-Dap(6DMN)-NH(2) (1) and H-Dmt-Tic-Glu-Dap(6DMN)-NH(2) (2)) were identified as potential fluorescent probes showing good properties for use in studies of distribution and internalization of delta receptors by confocal laser scanning microscopy. 相似文献